Lan
Lv3
250 积分
2021-11-18 加入
-
Challenges in developing personalized neoantigen cancer vaccines
11天前
已完结
-
Atezolizumab in combination with carboplatin plus nab-paclitaxel chemotherapy compared with chemotherapy alone as first-line treatment for metastatic non-squamous non-small-cell lung cancer (IMpower130): a multicentre, randomised, open-label, phase 3 trial
25天前
已完结
-
Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial
26天前
已完结
-
Real-world prevalence of programmed death ligand 1 expression in locally advanced or metastatic non–small-cell lung cancer: The global, multicenter EXPRESS study
1个月前
已完结
-
Antibody-drug conjugates for non-small cell lung cancer: Advantages and challenges in clinical translation
1个月前
已完结
-
B7-H3 regulates anti-tumor immunity and promotes tumor development in colorectal cancer
2个月前
已完结
-
Plinabulin plus docetaxel versus docetaxel in patients with non-small-cell lung cancer after disease progression on platinum-based regimen (DUBLIN-3): a phase 3, international, multicentre, single-blind, parallel group, randomised controlled trial
2个月前
已完结
-
Safety and tolerability of AMG 330 in adults with relapsed/refractory AML: a phase 1a dose-escalation study
3个月前
已完结
-
Multiscale Modeling of Antibody-Drug Conjugates: Connecting Tissue and Cellular Distribution to Whole Animal Pharmacokinetics and Potential Implications for Efficacy
6个月前
已完结
-
Computational transport analysis of antibody-drug conjugate bystander effects and payload tumoral distribution: implications for therapy
6个月前
已完结